Sustained delivery of bioactive cytokine using a dense collagen gel vehicle: Collagen gel delivery of bioactive cytokine

Sundaralingam Premaraj, Bethany L. Mundy, David Morgan, Phillip L. Winnard, Mark P. Mooney, Amr M. Moursi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: The use of cytokines as localized therapeutic agents is limited by the lack of a satisfactory delivery system. The aim of the current investigation was to determine the release kinetics and bioactivity of a simplified cytokine/collagen gel system designed to achieve extended, local delivery of bioactive cytokines at sites of premature cranial suture fusion (craniosynostosis). Design: Cytokine release was determined by ELISA measurements of Tgf-β3 collected in media. Cytokine bioactivity was determined by measuring the effect of conditioned media, containing released Tgf-β3, on mink lung epithelial cell proliferation and osteoblast alkaline phosphatase activity. Osteoblast response was evaluated by measuring proliferation of cells cultured on collagen gel containing Tgf-β3 using an AlamarBlue assay. Results: Gels loaded with 100 and 500 ng of Tgf-β3 produced a sustained release over 14 days with a pattern of initial large release followed by a gradual reduction in the amount released over the time. The reduced release over time was correlated to the amount initially loaded. Mink lung epithelial cell assay results indicated that Tgf-β3 released from the collagen gel retained its bioactivity following incorporation into the collagen gel and release into the media. This bioactivity was further illustrated by a decreased alkaline phosphatase activity measured in osteoblasts cultured on the gels loaded with Tgf-β3. Osteoblast proliferation assays demonstrated that the collagen gel has an inherent inhibitory effect on osteoblast cell number. Conclusions: This collagen gel/cytokine delivery system can retain and release bioactive cytokine over a prolonged period. These results will allow for better optimization of future in vitro and in vivo studies directed at improving the treatment of craniosynostosis.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalArchives of Oral Biology
Volume51
Issue number4
DOIs
StatePublished - Apr 1 2006

Fingerprint

Collagen
Gels
Cytokines
Osteoblasts
Mink
Craniosynostoses
Alkaline Phosphatase
Epithelial Cells
Cranial Sutures
Cell Proliferation
Lung
Conditioned Culture Medium
Cultured Cells
Cell Count
Enzyme-Linked Immunosorbent Assay
Therapeutics

Keywords

  • Collagen gel
  • Cranial suture
  • Drug delivery
  • Osteoblast
  • Tgf-β3

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Dentistry(all)
  • Cell Biology

Cite this

Sustained delivery of bioactive cytokine using a dense collagen gel vehicle : Collagen gel delivery of bioactive cytokine. / Premaraj, Sundaralingam; Mundy, Bethany L.; Morgan, David; Winnard, Phillip L.; Mooney, Mark P.; Moursi, Amr M.

In: Archives of Oral Biology, Vol. 51, No. 4, 01.04.2006, p. 325-333.

Research output: Contribution to journalArticle

Premaraj, Sundaralingam ; Mundy, Bethany L. ; Morgan, David ; Winnard, Phillip L. ; Mooney, Mark P. ; Moursi, Amr M. / Sustained delivery of bioactive cytokine using a dense collagen gel vehicle : Collagen gel delivery of bioactive cytokine. In: Archives of Oral Biology. 2006 ; Vol. 51, No. 4. pp. 325-333.
@article{adbf8dbc5707417198d981385807d625,
title = "Sustained delivery of bioactive cytokine using a dense collagen gel vehicle: Collagen gel delivery of bioactive cytokine",
abstract = "Objective: The use of cytokines as localized therapeutic agents is limited by the lack of a satisfactory delivery system. The aim of the current investigation was to determine the release kinetics and bioactivity of a simplified cytokine/collagen gel system designed to achieve extended, local delivery of bioactive cytokines at sites of premature cranial suture fusion (craniosynostosis). Design: Cytokine release was determined by ELISA measurements of Tgf-β3 collected in media. Cytokine bioactivity was determined by measuring the effect of conditioned media, containing released Tgf-β3, on mink lung epithelial cell proliferation and osteoblast alkaline phosphatase activity. Osteoblast response was evaluated by measuring proliferation of cells cultured on collagen gel containing Tgf-β3 using an AlamarBlue assay. Results: Gels loaded with 100 and 500 ng of Tgf-β3 produced a sustained release over 14 days with a pattern of initial large release followed by a gradual reduction in the amount released over the time. The reduced release over time was correlated to the amount initially loaded. Mink lung epithelial cell assay results indicated that Tgf-β3 released from the collagen gel retained its bioactivity following incorporation into the collagen gel and release into the media. This bioactivity was further illustrated by a decreased alkaline phosphatase activity measured in osteoblasts cultured on the gels loaded with Tgf-β3. Osteoblast proliferation assays demonstrated that the collagen gel has an inherent inhibitory effect on osteoblast cell number. Conclusions: This collagen gel/cytokine delivery system can retain and release bioactive cytokine over a prolonged period. These results will allow for better optimization of future in vitro and in vivo studies directed at improving the treatment of craniosynostosis.",
keywords = "Collagen gel, Cranial suture, Drug delivery, Osteoblast, Tgf-β3",
author = "Sundaralingam Premaraj and Mundy, {Bethany L.} and David Morgan and Winnard, {Phillip L.} and Mooney, {Mark P.} and Moursi, {Amr M.}",
year = "2006",
month = "4",
day = "1",
doi = "10.1016/j.archoralbio.2005.08.008",
language = "English (US)",
volume = "51",
pages = "325--333",
journal = "Archives of Oral Biology",
issn = "0003-9969",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Sustained delivery of bioactive cytokine using a dense collagen gel vehicle

T2 - Collagen gel delivery of bioactive cytokine

AU - Premaraj, Sundaralingam

AU - Mundy, Bethany L.

AU - Morgan, David

AU - Winnard, Phillip L.

AU - Mooney, Mark P.

AU - Moursi, Amr M.

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Objective: The use of cytokines as localized therapeutic agents is limited by the lack of a satisfactory delivery system. The aim of the current investigation was to determine the release kinetics and bioactivity of a simplified cytokine/collagen gel system designed to achieve extended, local delivery of bioactive cytokines at sites of premature cranial suture fusion (craniosynostosis). Design: Cytokine release was determined by ELISA measurements of Tgf-β3 collected in media. Cytokine bioactivity was determined by measuring the effect of conditioned media, containing released Tgf-β3, on mink lung epithelial cell proliferation and osteoblast alkaline phosphatase activity. Osteoblast response was evaluated by measuring proliferation of cells cultured on collagen gel containing Tgf-β3 using an AlamarBlue assay. Results: Gels loaded with 100 and 500 ng of Tgf-β3 produced a sustained release over 14 days with a pattern of initial large release followed by a gradual reduction in the amount released over the time. The reduced release over time was correlated to the amount initially loaded. Mink lung epithelial cell assay results indicated that Tgf-β3 released from the collagen gel retained its bioactivity following incorporation into the collagen gel and release into the media. This bioactivity was further illustrated by a decreased alkaline phosphatase activity measured in osteoblasts cultured on the gels loaded with Tgf-β3. Osteoblast proliferation assays demonstrated that the collagen gel has an inherent inhibitory effect on osteoblast cell number. Conclusions: This collagen gel/cytokine delivery system can retain and release bioactive cytokine over a prolonged period. These results will allow for better optimization of future in vitro and in vivo studies directed at improving the treatment of craniosynostosis.

AB - Objective: The use of cytokines as localized therapeutic agents is limited by the lack of a satisfactory delivery system. The aim of the current investigation was to determine the release kinetics and bioactivity of a simplified cytokine/collagen gel system designed to achieve extended, local delivery of bioactive cytokines at sites of premature cranial suture fusion (craniosynostosis). Design: Cytokine release was determined by ELISA measurements of Tgf-β3 collected in media. Cytokine bioactivity was determined by measuring the effect of conditioned media, containing released Tgf-β3, on mink lung epithelial cell proliferation and osteoblast alkaline phosphatase activity. Osteoblast response was evaluated by measuring proliferation of cells cultured on collagen gel containing Tgf-β3 using an AlamarBlue assay. Results: Gels loaded with 100 and 500 ng of Tgf-β3 produced a sustained release over 14 days with a pattern of initial large release followed by a gradual reduction in the amount released over the time. The reduced release over time was correlated to the amount initially loaded. Mink lung epithelial cell assay results indicated that Tgf-β3 released from the collagen gel retained its bioactivity following incorporation into the collagen gel and release into the media. This bioactivity was further illustrated by a decreased alkaline phosphatase activity measured in osteoblasts cultured on the gels loaded with Tgf-β3. Osteoblast proliferation assays demonstrated that the collagen gel has an inherent inhibitory effect on osteoblast cell number. Conclusions: This collagen gel/cytokine delivery system can retain and release bioactive cytokine over a prolonged period. These results will allow for better optimization of future in vitro and in vivo studies directed at improving the treatment of craniosynostosis.

KW - Collagen gel

KW - Cranial suture

KW - Drug delivery

KW - Osteoblast

KW - Tgf-β3

UR - http://www.scopus.com/inward/record.url?scp=33644845403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644845403&partnerID=8YFLogxK

U2 - 10.1016/j.archoralbio.2005.08.008

DO - 10.1016/j.archoralbio.2005.08.008

M3 - Article

C2 - 16226216

AN - SCOPUS:33644845403

VL - 51

SP - 325

EP - 333

JO - Archives of Oral Biology

JF - Archives of Oral Biology

SN - 0003-9969

IS - 4

ER -